These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25964383)

  • 1. Altered activities of kininase II, an angiotensin converting enzyme, prekallikrein, and nitric oxide in Kuwaiti patients with type 2 diabetes.
    Sharma JN; Al-Shoumer K; Matar KM; Madathil NV; Al-Moalem A
    Int J Immunopathol Pharmacol; 2015 Jun; 28(2):240-6. PubMed ID: 25964383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.
    Ito A; Egashira K; Narishige T; Muramatsu K; Takeshita A
    Circ J; 2002 Sep; 66(9):811-5. PubMed ID: 12224817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium.
    Kitakaze M; Node K; Minamino T; Asanuma H; Ueda Y; Kosaka H; Kuzuya T; Hori M
    J Mol Cell Cardiol; 1998 Nov; 30(11):2461-6. PubMed ID: 9925380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prekallikrein and high angiotensin-converting enzyme activity in patients with chronic renal failure on haemodialysis.
    Jankova T; Tchankova P; Nenov D
    Nephrol Dial Transplant; 1991; 6 Suppl 3():6-9. PubMed ID: 1663601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
    Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition.
    Henriksen EJ; Jacob S
    J Cell Physiol; 2003 Jul; 196(1):171-9. PubMed ID: 12767053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphate binding reduces aortic angiotensin-converting enzyme and enhances nitric oxide bioactivity in experimental renal insufficiency.
    Eräranta A; Törmänen S; Kööbi P; Vehmas TI; Lakkisto P; Tikkanen I; Moilanen E; Niemelä O; Mustonen J; Pörsti I
    Am J Nephrol; 2014; 39(5):400-8. PubMed ID: 24818649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart.
    Katwa LC; Ratajska A; Cleutjens JP; Sun Y; Zhou G; Lee SJ; Weber KT
    Cardiovasc Res; 1995 Jan; 29(1):57-64. PubMed ID: 7895240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
    Krairittichai U; Chaisuvannarat V
    J Med Assoc Thai; 2009 May; 92(5):611-7. PubMed ID: 19459520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy.
    Ustündağ B; Canatan H; Cinkilinç N; Halifeoğlu I; Bahçecioğlu IH
    Cell Biochem Funct; 2000 Mar; 18(1):23-8. PubMed ID: 10686580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced angiotensin-converting enzyme activity and impaired endothelium-dependent vasodilation in aortae from hypertensive rats: evidence for a causal link.
    Goetz RM; Holtz J
    Clin Sci (Lond); 1999 Aug; 97(2):165-74. PubMed ID: 10409471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.